RESUMEN
The case of an elderly immunocompromised man with non-Hodgkin's lymphoma who presented with fever, abdominal pain and bloody diarrhea is described. Brachyspira pilosicoli was isolated from culture. The patient was treated with penicillin G i.v. and became afebrile. B. pilosicoli is a recently recognized enteric pathogen of humans and animals. Intestinal spirochetosis should be included in the differential diagnosis of any immunocompromised or critically ill patient with dysentery.
Asunto(s)
Bacteriemia/diagnóstico , Brachyspira/aislamiento & purificación , Disentería Bacilar/diagnóstico , Huésped Inmunocomprometido , Penicilina G/administración & dosificación , Infecciones por Spirochaetales/diagnóstico , Infecciones por Spirochaetales/tratamiento farmacológico , Anciano , Bacteriemia/tratamiento farmacológico , Disentería Bacilar/tratamiento farmacológico , Disentería Bacilar/inmunología , Estudios de Seguimiento , Anciano Frágil , Humanos , Infusiones Intravenosas , Linfoma no Hodgkin/diagnóstico , Linfoma no Hodgkin/inmunología , Masculino , Medición de Riesgo , Resultado del TratamientoRESUMEN
OBJECTIVES: The aim of our study was the molecular typing of 40 clinical isolates of Candida spp. obtained from patients with burns or trauma hospitalized in the intensive care unit of a general hospital. METHODS: Isolates were recovered from blood, deep trauma, urine, sputum or from environment within a short period of time (4 months). The yeasts were identified using commercial yeast identification kits as C. albicans (17 isolates), C. tropicalis (16 isolates) and C. parapsilosis (10 isolates). The epidemiological relation of the isolates was tested with the Random Amplified Polymorphic DNA assay using three or four arbitrary chosen primers. RESULTS: All C. albicans isolates presented distinct RAPD profiles, C. tropicalis isolates presented both the same and distinct RAPD patterns and the C. parapsilosis isolates presented the same RAPD pattern. All the environmental isolates were identified as C. parapsilosis and they had the same RAPD pattern as C. parapsilosis clinical isolates. Candida parapsilosis delineation was confirmed with PFGE. CONCLUSIONS: The colonization/infection with C. albicans was endogenous, the C. tropicalis colonization/infection was both endogenous and exogenous, and the C. parapsilosis colonization/infection had an environmental origin.
Asunto(s)
Quemaduras/microbiología , Candida/clasificación , Candidiasis/microbiología , Heridas y Lesiones/microbiología , Candida/genética , Candida albicans/clasificación , Candida albicans/genética , Candidiasis/epidemiología , ADN de Hongos/análisis , Electroforesis en Gel de Campo Pulsado , Fungemia/microbiología , Hospitalización , Humanos , Unidades de Cuidados Intensivos , Técnicas de Tipificación Micológica , Técnica del ADN Polimorfo Amplificado AleatorioRESUMEN
Ten severely immunocompromised HIV-HCV co-infected patients were enrolled in a quantifiable HCV-RNA assay. Serum alanine aminotransferase, HCV-RNA levels and HIV viral loads were determined at baseline, at month three and at month six after initiation of a highly active antiretroviral therapy including an HIV protease inhibitor. HCV genotypes were determined using a line probe assay kit. Our results suggested that this therapy did not result in lower HCV viraemia, whatever the HCV genotypes, and probably had no effect on the outcome of chronic viral hepatitis C. As our patients were severely immunocompromised and their mean increase of CD4 cell counts was less than 50/mm(3), we cannot reach any conclusions about the impact of the improvement of immune status on the HCV-RNA load.
Asunto(s)
Terapia Antirretroviral Altamente Activa , Infecciones por VIH/complicaciones , Inhibidores de la Proteasa del VIH/uso terapéutico , Hepacivirus/efectos de los fármacos , Hepatitis C/complicaciones , Hepatitis C/virología , Recuento de Linfocito CD4 , VIH/efectos de los fármacos , VIH/fisiología , Infecciones por VIH/tratamiento farmacológico , Infecciones por VIH/inmunología , Infecciones por VIH/virología , Hepacivirus/fisiología , Hepatitis C/tratamiento farmacológico , Hepatitis C/inmunología , Humanos , Indinavir/uso terapéutico , ARN Viral/sangre , Inhibidores de la Transcriptasa Inversa/uso terapéutico , Ritonavir/uso terapéutico , Carga Viral , Viremia/virología , Replicación Viral/efectos de los fármacosRESUMEN
Mycobacterium genavense is a recently described microorganism causing disseminated infections in AIDS patients. In this study, we investigate its pathogenicity in mice and some mechanisms of the host response to this bacterium. Following an intravenous challenge of 10(6) organisms, M. genavense grew progressively in the spleens and livers of BALB/c and CBA mice over at least an 8-month period. Granulomas were present in the spleens, livers and lungs of the animals. The numbers of bacteria recovered from the spleens and livers were higher in BALB/c (Bcg(s)) than in CBA (Bcg(r)) mice from day 30. The role of the Bcg gene, in the early phase of infection, was supported by the fact that the bacterial load, on day 15, was higher in BALB/c than in the congenic C.D2 (Bcg(r)) mice. The role of T cells in the host response was suggested by the high susceptibility of nude mice to M. genavense infection. In vivo depletion experiments in CBA mice indicated that gamma interferon and both CD4(+) and CD8(+) T cells participate in the containment of the bacterial load.
Asunto(s)
Proteínas de Transporte de Catión , Infecciones por Mycobacterium/inmunología , Infecciones por Mycobacterium/microbiología , Mycobacterium/patogenicidad , Animales , Anticuerpos Monoclonales/inmunología , Linfocitos T CD4-Positivos/inmunología , Linfocitos T CD8-positivos/inmunología , Proteínas Portadoras/genética , Recuento de Colonia Microbiana , Femenino , Granuloma/microbiología , Granuloma/patología , Inmunidad Innata , Interferón gamma/inmunología , Hígado/microbiología , Hígado/patología , Pulmón/microbiología , Pulmón/patología , Depleción Linfocítica , Proteínas de la Membrana/genética , Ratones , Ratones Endogámicos BALB C , Ratones Endogámicos CBA , Ratones Desnudos , Mycobacterium/aislamiento & purificación , Infecciones por Mycobacterium/patología , Pruebas de Neutralización , Bazo/microbiología , Bazo/patologíaRESUMEN
OBJECTIVES: Sixteen Mycobacterium avium strains were isolated from the blood of eight AIDS patients over a period of months. All the patients were on combination therapies including clarithromycin, and all had treatment failure and relapses of M.avium bacteremia. Paired clarithromycin-sensitive and resistant M.avium strains isolated at the beginning of treatment and at the first relapse of bacteremia were compared. METHODS: The M.avium isolates were identified after hybridization with DNA probes specific for M.avium rRNA and typed epidemiologically with random amplified polymorphic DNA analyses using three arbitrary primers. The rate of intracellular cell entry or the tumour necrosis factor alpha induction by the M.avium isolates were studied in human monocytes and J774 cells. RESULTS: When the M.avium isolates were hybridized with the rRNA probes, we obtained lower hybridization values with clarithromycin-resistant isolates than with clarithromycin-sensitive isolates. This appeared to be due to smaller amounts of rRNA available for hybridization than to mutation of the 23S rRNA sequences in clarithromycin-resistant strains. The RAPD analyses showed that the clarithromycin-resistant isolates were clonally related to the clarithromycin-sensitive strains in six of the eight patients. The other two patients had a RAPD profile, suggesting a re-infection and/or polyclonal infection. The M.avium isolates obtained on day 0 and after the emergence of resistance to clarithromycin did not differ in terms of their intracellular entry rate, or in terms of tumour necrosis factor alpha induction. CONCLUSIONS: We infer that M.avium strains isolated during bacteraemic relapses on combination therapies including clarithromycin are epidemiologically related to the initial strain and do not show changes in the rate of intracellular cell entry and in terms of tumour necrosis factor alpha induction. Re-infections and/or polyclonal infections however, although less frequent, can also occur.
Asunto(s)
Infecciones Oportunistas Relacionadas con el SIDA/microbiología , Antibacterianos/farmacología , Claritromicina/farmacología , Complejo Mycobacterium avium/efectos de los fármacos , Infección por Mycobacterium avium-intracellulare/microbiología , Infecciones Oportunistas Relacionadas con el SIDA/tratamiento farmacológico , Antibacterianos/uso terapéutico , Antituberculosos/farmacología , Antituberculosos/uso terapéutico , Bacteriemia/microbiología , Línea Celular , Claritromicina/uso terapéutico , ADN Bacteriano/análisis , Quimioterapia Combinada , Humanos , Pruebas de Sensibilidad Microbiana , Monocitos/microbiología , Complejo Mycobacterium avium/genética , Complejo Mycobacterium avium/aislamiento & purificación , Infección por Mycobacterium avium-intracellulare/tratamiento farmacológico , Hibridación de Ácido Nucleico , Técnica del ADN Polimorfo Amplificado Aleatorio , Recurrencia , Factor de Necrosis Tumoral alfa/metabolismoAsunto(s)
ADN Bacteriano/sangre , ADN Bacteriano/orina , Legionella pneumophila/aislamiento & purificación , Enfermedad de los Legionarios/diagnóstico , Humanos , Legionella pneumophila/genética , Reacción en Cadena de la Polimerasa , ARN Ribosómico 5S/genética , Juego de Reactivos para Diagnóstico , Sensibilidad y EspecificidadRESUMEN
OBJECTIVE: To compare the chromosomal types of Mycobacterium avium strains infecting HIV-negative and AIDS patients in Greece. METHODS: In total, 41 Mycobacterium avium isolates, 23 from AIDS and 18 from HIV-negative patients, were compared by pulsed-field gel electrophoresis of genomic DNA after XbaI digestion. The majority (87%) of AIDS isolates were from disseminated infection, while the majority (61%) of HIV-negative isolates were from children with cervical lymphadenitis. RESULTS: Pulsed-field gel electrophoresis classified strains whose electrophoretic patterns were at least 85% similar into three clusters, A (four isolates), B (12 isolates), and C (15), while 10 isolates remained outside of these clusters. There was no statistically significant correlation of any PFGE cluster with a specific patient group. Within each patient group, no significant correlation of PFGE type with time, place of residence or, in the case of AIDS patients, hospital attended was observed. CONCLUSIONS: Genotypic similarities between isolates responsible for disseminated infection in AIDS patients and lymphadenitis in HIV-negative children suggest that related strains, possibly from an environmental source, cause both types of infections.
Asunto(s)
Infecciones Oportunistas Relacionadas con el SIDA/microbiología , Síndrome de Inmunodeficiencia Adquirida/microbiología , Mycobacterium avium/clasificación , Infecciones Oportunistas Relacionadas con el SIDA/sangre , Síndrome de Inmunodeficiencia Adquirida/sangre , Síndrome de Inmunodeficiencia Adquirida/complicaciones , Adolescente , Adulto , Anciano , Niño , Preescolar , Análisis por Conglomerados , ADN Bacteriano/química , ADN Bacteriano/genética , Desoxirribonucleasas de Localización Especificada Tipo II/química , Electroforesis en Gel de Campo Pulsado , Femenino , Grecia , Humanos , Masculino , Persona de Mediana Edad , Mycobacterium avium/genética , Mycobacterium avium/aislamiento & purificación , Filogenia , Tuberculosis Ganglionar/microbiologíaRESUMEN
Arbitrarily primed PCR with three primers and pulsed-field gel electrophoresis were used to characterize a set of 75 clinical Legionella pneumophila serogroup 1 isolates, with no apparent epidemiological link, obtained from 24 hospitals in Paris, France, from 1987 to 1997. Unexpectedly, 25 clinical isolates from 15 hospitals had an identical profile (termed type A) by both methods. The same profile was subsequently found in 16 of 64 randomly selected environmental L. pneumophila serogroup 1 isolates from 15 different sites in the Paris area. There was no evidence of geographic clustering or a peak incidence of type A isolation. Type A has not been found in France outside the Paris area, suggesting that a particular type of L. pneumophila serogroup 1 is specifically present in the Paris water distribution network.
Asunto(s)
Legionella pneumophila/genética , Enfermedad de los Legionarios/microbiología , Técnicas de Tipificación Bacteriana , Francia/epidemiología , Humanos , Legionella pneumophila/clasificación , Legionella pneumophila/aislamiento & purificación , Enfermedad de los Legionarios/sangre , Enfermedad de los Legionarios/epidemiología , Paris/epidemiología , SerotipificaciónRESUMEN
The rise of Mycobacterium genavense infections is making identification ever more important for diagnosis and treatment. Moreover, isolation and identification of M. genavense are made difficult by the lack of growth on solid media and by its low generation rate in BACTEC liquid media. Thus, amplification by PCR or similar techniques represents the only possibility of detecting and identifying M. genavense from tissue samples. In order to set up a simple and species-specific method based on the use of PCR and non-radioactive hybridization technique, we decided to search for and clone a specific DNA fragment of this bacterial species. In the present study, a 1734-bp fragment was isolated. This fragment was found to be highly specific for M. genavense strains. A species-specific pair of primers (MG22 and MG23) and two oligonucleotide probes (MG18 and MG19) were selected. They were successfully used to amplify and detect a 155-bp DNA fragment from the 13 available strains of M. genavense which were isolated from clinical specimens or from birds. Conversely, the primers and probes did not hybridize with DNA from any of the 20 other mycobacterial species tested. It is worth noting that the chosen primers and probes did not hybridize with DNA of M. simiae, although it is closely related to M. genavense. The present PCR technique uses species-specific primers for M. genavense. Followed by a non-radioactive hybridization technique on microplates it is able to distinguish M. genavense from other mycobacteria in one step, without sequencing or restriction analysis. On the basis of the Southern blot hybridization, PCR and sandwich hybridization results, we concluded that the isolated 1.7-kb sequence was specific for the M. genavense chromosome. The method developed here for M. genavense identification uses a simple methodology and commonly available reagents. Furthermore it can be easily automated.
Asunto(s)
ADN Bacteriano/análisis , Mycobacterium/aislamiento & purificación , Reacción en Cadena de la Polimerasa/métodos , Secuencia de Bases , Southern Blotting , Sondas de ADN , Genoma Bacteriano , Humanos , Datos de Secuencia Molecular , Mycobacterium/genética , Hibridación de Ácido Nucleico , Análisis de Secuencia de ADNRESUMEN
Mycobacterium genavense is a recently described agent which can induce disseminated infections in patients with AIDS. Up to now, no standard approach to treatment has been defined and patients have been treated empirically with antibiotics used for treating infections caused by other nontuberculous mycobacteria. In this study, we compared the effectiveness of ciprofloxacin, amikacin, ethambutol, clarithromycin and rifabutin in the treatment of an animal model of M. genavense infection in C57BL/6 mice. Antimycobacterial treatment was started 4 weeks after an intravenous bacterial challenge and was continued for 30 days. Treated and control mice were killed at days 15 and 30 of treatment and the number of viable bacteria in their spleens was counted. Treatment with clarithromycin (50 mg/kg/day sc) and rifabutin (20 mg/kg/day po) was found to decrease the bacterial counts in the spleens significantly as early as 15 days after the onset of treatment (P < 0.01). The effect of treatment was more pronounced after 30 days of treatment (P < 0.001). Amikacin (25 mg/kg/day sc) and ethambutol (50 mg/kg/day sc) were found to decrease significantly the cfu in the spleens only after 30 days of treatment (P < 0.01). Ciprofloxacin (25 mg/kg/day sc) was ineffective in the experimental conditions used here.
Asunto(s)
Antibacterianos/uso terapéutico , Infecciones por Mycobacterium/tratamiento farmacológico , Mycobacterium , Amicacina/uso terapéutico , Animales , Ciprofloxacina/uso terapéutico , Claritromicina/uso terapéutico , Quimioterapia Combinada , Etambutol/uso terapéutico , Femenino , Ratones , Ratones Endogámicos C57BL , Infecciones por Mycobacterium/microbiología , Rifabutina/uso terapéutico , Bazo/microbiologíaRESUMEN
Mycobacterium gordonae was isolated as a light growth from bronchoalveolar aspirates from nine patients over 12 months. All patients were in one hospital, and had been bronchoscoped for suspected malignancy. None of the patients had symptoms or radiographic findings of mycobacterial infection. The isolates were characterized by biochemical tests and molecular hybridization. Random amplified polymorphic DNA analysis (RAPD) was used to test whether the strains had a common origin. All the isolates generated four to eight fragments, and almost all presented distinct RAPD patterns. Antimicrobial resistance patterns to six agents confirmed that the isolates were unrelated. Thus epidemiologically unrelated strains of M. gordonae can exist as contaminants in the same department over a relatively short time frame. RAPD analysis is easy to perform, gives rapid results, and can be used for epidemiological analysis of M. gordonae isolates.
Asunto(s)
Infección Hospitalaria/microbiología , ADN Bacteriano/análisis , Infecciones por Mycobacterium no Tuberculosas/microbiología , Micobacterias no Tuberculosas/clasificación , Técnica del ADN Polimorfo Amplificado Aleatorio , Dermatoglifia del ADN/métodos , Farmacorresistencia Microbiana , Marcadores Genéticos , Humanos , Control de Infecciones , Micobacterias no Tuberculosas/genética , Reproducibilidad de los Resultados , Serotipificación/métodosRESUMEN
There is a geographic distribution of Mycobacterium tuberculosis strains with various rpoB gene mutations that account for rifampin resistance. We studied 17 rifampin-resistant clinical isolates from patients in Greece to identify rpoB mutations. The aim of our study was the evaluation of a commercially available line probe assay kit (INNO-LiPA Rif. TB) to detect rpoB mutations and rifampin resistance. The results obtained with the commercially available assay were compared to those obtained by automated DNA sequence analysis of amplified PCR products. Randomly amplified polymorphic DNA (RAPD) analyses of the isolates were also performed. The overall concordance of the line probe assay with phenotypic rifampin susceptibility test was 94%. Three distinct rpoB mutations in codons Ser531, His526, and Asp516 were correctly identified with the kit, but mutations in external regions and insertions were detected only by automated DNA sequence analysis. The changes in codons Ser531 and His526 accounted for the majority of rifampin resistance, as previously described for isolates from other geographic areas. The results obtained by RAPD analyses of the isolates suggested that clonally related M. tuberculosis strains can have subclones bearing distinct mutant rpoB alleles. We conclude that this line probe assay kit, which is fast and with which tests are easy to perform, can be used for the rapid detection of rifampin resistance in M. tuberculosis before the availability of results by conventional methods and for epidemiological studies but that negative results obtained by this method do not rule out rifampin resistance.
Asunto(s)
Antibióticos Antituberculosos/farmacología , Mutación , Mycobacterium tuberculosis/efectos de los fármacos , Proteínas de Plantas/genética , Rifampin/farmacología , Secuencia de Aminoácidos , Secuencia de Bases , ARN Polimerasas Dirigidas por ADN , Farmacorresistencia Microbiana , Datos de Secuencia Molecular , Mycobacterium tuberculosis/genéticaRESUMEN
Forty human clinical Mycobacterium avium-M. intracellulare complex strains isolated in Greece were characterized to the species level by PCR with three sets of primers specific for one or both species. M. avium predominated in both human immunodeficiency virus-positive and -negative patients, but the frequency of M. intracellulare isolation appeared to be higher in the latter.
Asunto(s)
Infecciones Oportunistas Relacionadas con el SIDA/microbiología , Complejo Mycobacterium avium/clasificación , Infección por Mycobacterium avium-intracellulare/microbiología , Infecciones Oportunistas Relacionadas con el SIDA/clasificación , Infecciones Oportunistas Relacionadas con el SIDA/epidemiología , Adulto , Niño , Cartilla de ADN , Mucosa Gástrica/microbiología , Grecia , Seronegatividad para VIH , Humanos , Incidencia , Ganglios Linfáticos/microbiología , Ganglios Linfáticos/patología , Complejo Mycobacterium avium/aislamiento & purificación , Infección por Mycobacterium avium-intracellulare/epidemiología , Infección por Mycobacterium avium-intracellulare/patología , Reacción en Cadena de la Polimerasa/métodos , Esputo/microbiología , Irrigación TerapéuticaRESUMEN
Rhodococcus equi is a facultative intracellular bacterium that can cause pneumonia in both young horses and immunocompromised humans. In this study, we have tried to determine the T-cell populations that recognize this pathogen during murine infection, as well as the bacterial antigens recognized by these cells. When BALB/c mice were hyperimmunized with a virulent R. equi strain, we did not observe preferential expansion of a particular T-cell subset in their spleens. However, when the splenic T lymphocytes of the hyperimmunized BALB/c mice were cultured in the presence of killed bacteria, we found that alpha/beta CD4+ T cells proliferated and exhibited increased levels of the interleukin-2 receptor (IL2R). In order to ensure antigen specificity, two different controls were included in these experiments: (i) T-cell proliferation and expression of the IL2R in the presence of the major membrane constituent of Bacillus megaterium were studied comparatively with the presence of the R. equi bacterial antigen, and (ii) T-cell proliferation and expression of the IL2R from naive, non-infected mice in the presence of bacterial antigens were compared to those observed in hyperimmunized mice. In our study, the T cells from hyperimmunized mice did not significantly proliferate nor were they activated in the presence of non-related bacterial antigens, and T cells from naive mice were not found to significantly recognize R. equi antigens. When we studied the localization of R. equi antigens that could stimulate the in vitro proliferation and activation of T cells, we found that they were constituents of the bacterial cell wall and the cytoplasm, but they were not excreted in the culture medium. For these experiments, T-cell recognition of the bacterial antigens in hyperimmunized mice was compared to that of naive mice. With T-cell immunoblotting, we found that T-cell proliferation and activation were obtained with proteins having molecular masses of approximately 65, 43, 30, 22-27 and 15-17 kDa. It is noteworthy that among the recognized bacterial antigens, some have been described as being associated with virulence.
Asunto(s)
Infecciones por Actinomycetales/inmunología , Rhodococcus equi/inmunología , Linfocitos T/inmunología , Animales , Antígenos Bacterianos/inmunología , Femenino , Activación de Linfocitos , Ratones , Ratones Endogámicos BALB C , Subgrupos de Linfocitos T/inmunologíaRESUMEN
A randomly amplified polymorphic DNA (RAPD) analysis was performed for the molecular typing of Mycobacterium avium strains. This method was applied to epidemiologically unrelated M. avium strains isolated from the blood of 10 different AIDS patients and to strains that were considered epidemiologically related, as they had been isolated from the same patient but from different body locations (4 patients, 10 strains). Three oligonucleotide primers among the six tested were found to generate RAPD profiles with DNA from all M. avium strains and to successfully type them. This method for the typing of M. avium strains is rapid and easy to perform.
Asunto(s)
Infecciones Oportunistas Relacionadas con el SIDA/microbiología , Técnicas de Tipificación Bacteriana , Complejo Mycobacterium avium/clasificación , Infección por Mycobacterium avium-intracellulare/microbiología , Técnica del ADN Polimorfo Amplificado Aleatorio , Médula Ósea/microbiología , Cartilla de ADN , ADN Bacteriano/análisis , ADN Bacteriano/sangre , Humanos , Complejo Mycobacterium avium/genética , Complejo Mycobacterium avium/aislamiento & purificación , Esputo/microbiologíaRESUMEN
Ninety-eight consecutive clinical isolates of Legionella pneumophila were tested for erythromycin, rifampicin and ciprofloxacin susceptibility. MICs, determined by agar dilution testing, were in the range 0.06-1 mg/L of erythromycin, 0.007-0.015 mg/L of rifampicin and 0.015-0.03 mg/L of ciprofloxacin. No resistance against the antibiotics tested was detected. It is thus likely that therapeutic failures in legionnaires' disease are not related to the emergence of resistance against commonly used antimicrobial agents.
Asunto(s)
Antibacterianos/farmacología , Ciprofloxacina/farmacología , Eritromicina/farmacología , Legionella pneumophila/efectos de los fármacos , Rifampin/farmacología , Antiinfecciosos/farmacología , Antibióticos Antituberculosos/farmacología , Farmacorresistencia Microbiana/fisiología , Legionella pneumophila/metabolismo , Pruebas de Sensibilidad MicrobianaRESUMEN
Twenty-four cerebrospinal fluid (CSF) samples from 19 AIDS patients with neurological signs were analysed by the polymerase chain reaction (PCR) for the presence of JC virus (JCV). Eleven of the 19 patients tested presented with progressive multifocal leucoencephalopathy (PML). Two specific JCV target sequences were used for the PCR analysis: a sequence specific for the T antigen genes from both BK virus (BKV) and JCV (PCR1) and a sequence specific for the large T antigen gene from JCV (PCR2). The JCV genome was detected in 10 of 11 patients with PML by the PCR1 method and in all 11 patients by the PCR2 method. With samples from the eight patients without PML, one positive result was obtained with the PCR1 method and this sample and another gave positive results with PCR2. Multiple CSF samples were collected from three patients with PML at different times, including after intrathecal cytarabine treatment, and were tested by the PCR2 method for the presence of the JCV genome. The PCR result became negative for two of the three patients during the cytarabine treatment. However, the absence of a PCR signal was not associated with clinical improvement in these patients. The PCR method is useful for the detection of JCV in CSF samples and in the diagnosis of PML. However, the application of PCR for monitoring the effect of treatment remains to be established.